Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Picot, N; Le Mener, V; Rotivel, Y; Schonfeld, C; Cetre, JC; Costy, F; Grillet, JP; Lanta, N; Lang, J
   Booster effect of a new chromatographically purified Vero-cell rabies vaccine (CPRV): immunogenicity and safety of a single or double injection
   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
   
   N. Picot et al., "Booster effect of a new chromatographically purified Vero-cell rabies vaccine (CPRV): immunogenicity and safety of a single or double injection", T RS TROP M, 95(3), 2001, pp. 342-344
2. Lang, J; Cetre, JC; Picot, N; Lanta, M; Briantais, P; Vital, S; Le Mener, V; Lutsch, C; Rotivel, Y
   Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV)
   BIOLOGICALS
   
   J. Lang et al., "Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV)", BIOLOGICALS, 26(4), 1998, pp. 299-308
3. MARCHOU B; PICOT N; MASSIP P
   VACCINATING THE TRAVELER
   Annales de medecine interne
   
   B. Marchou et al., "VACCINATING THE TRAVELER", Annales de medecine interne, 149(6), 1998, pp. 332-339
4. GARIN L; BERNAUD J; PICOT N; SALVI M; CORALLO F; BLOY C; RIGAL D
   RU-41-740 (BIOSTIM) AND IL-4, OR IL-13, HAVE OPPOSITE EFFECTS ON CD14, CD23, HLA-DR AND HLA-DQ ON MONOCYTES
   International journal of immunopharmacology
   
   L. Garin et al., "RU-41-740 (BIOSTIM) AND IL-4, OR IL-13, HAVE OPPOSITE EFFECTS ON CD14, CD23, HLA-DR AND HLA-DQ ON MONOCYTES", International journal of immunopharmacology, 18(1), 1996, pp. 69-74
5. PICOT N; OLIVE F; MARCHOU B; TARDY JC; AYMARD M
   IMMUNOLOGICAL STATUS OF FRENCH ADULT TRAV ELERS BEFORE DEPARTURE - RESULTS OF A MULTICENTRIC SEROEPIDEMIOLOGICAL STUDY
   Medecine et maladies infectieuses
   
   N. Picot et al., "IMMUNOLOGICAL STATUS OF FRENCH ADULT TRAV ELERS BEFORE DEPARTURE - RESULTS OF A MULTICENTRIC SEROEPIDEMIOLOGICAL STUDY", Medecine et maladies infectieuses, 25(11), 1995, pp. 1137-1141
6. MARCHOU B; EXCLER JL; BOURDERIOUX C; SALAUN J; PICOT N; YVONNET B; CERISIER JE; SALOMON H; AUVERGNAT JC
   A 3-WEEK HEPATITIS-B VACCINATION SCHEDULE PROVIDES RAPID AND PERSISTENT PROTECTIVE IMMUNITY - A MULTICENTER, RANDOMIZED TRIAL COMPARING ACCELERATED AND CLASSIC VACCINATION SCHEDULES
   The Journal of infectious diseases
   
   B. Marchou et al., "A 3-WEEK HEPATITIS-B VACCINATION SCHEDULE PROVIDES RAPID AND PERSISTENT PROTECTIVE IMMUNITY - A MULTICENTER, RANDOMIZED TRIAL COMPARING ACCELERATED AND CLASSIC VACCINATION SCHEDULES", The Journal of infectious diseases, 172(1), 1995, pp. 258-260
7. MARCHOU B; PICOT N; CHAVANET P; AUVERGNAT JC; ARMENGAUD M; DEVILLIERS P; CERISIER JE; MARIE FN; EXCLER JL
   3-WEEK HEPATITIS-B VACCINATION PROVIDES PROTECTIVE IMMUNITY
   Vaccine
   
   B. Marchou et al., "3-WEEK HEPATITIS-B VACCINATION PROVIDES PROTECTIVE IMMUNITY", Vaccine, 11(14), 1993, pp. 1383-1385
8. PICOT N; RECEVEUR MC; GOUJON C; ARMENGAUD M
   TRAVELER GOING ABROAD - WHAT HE NEEDS TO KNOW
   Bulletin de la Societe de pathologie exotique et de ses filiales
   
   N. Picot et al., "TRAVELER GOING ABROAD - WHAT HE NEEDS TO KNOW", Bulletin de la Societe de pathologie exotique et de ses filiales, 86(5BIS), 1993, pp. 418-420
9. ARMENGAUD M; PICOT N; PICCOLI S
   EVOLUTION AND TENDENCIES, FROM 1986 TO 19 93, OF THE ATTITUDE OF INTERCONTINENTAL TRAVELERS, IN DEPARTURE FROM FRANCE, TOWARDS ANTIMALARIALPROPHYLAXIS
   Bulletin de la Societe de pathologie exotique et de ses filiales
   
   M. Armengaud et al., "EVOLUTION AND TENDENCIES, FROM 1986 TO 19 93, OF THE ATTITUDE OF INTERCONTINENTAL TRAVELERS, IN DEPARTURE FROM FRANCE, TOWARDS ANTIMALARIALPROPHYLAXIS", Bulletin de la Societe de pathologie exotique et de ses filiales, 86(5BIS), 1993, pp. 421-423